Xeris Biopharma Ownership | Who Owns Xeris Biopharma?
Xeris Biopharma Ownership Summary
Xeris Biopharma is owned by 42.83% institutional investors, 3.91% insiders, and 53.26% retail investors. Blackrock is the largest institutional shareholder, holding 7.35% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Xeris Biopharma shares.
XERS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Xeris Biopharma | 42.83% | 3.91% | 53.26% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 10.33M | 7.35% | $23.25M |
| Vanguard group | 7.66M | 5.45% | $17.23M |
| Caxton | 5.11M | 3.64% | $11.51M |
| State street | 3.26M | 2.32% | $7.33M |
| Geode capital management | 3.24M | 2.31% | $7.29M |
| Rosalind advisors | 3.12M | 2.22% | $7.02M |
| Millennium management | 1.70M | 1.21% | $3.82M |
| Morgan stanley | 1.61M | 1.15% | $3.62M |
| Centerbook partners lp | 1.47M | 1.04% | $3.30M |
| Renaissance | 1.35M | 0.96% | $3.04M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caxton | 5.11M | 58.31% | $11.51M |
| Rosalind advisors | 3.12M | 5.40% | $7.02M |
| Knott david m jr | 820.00K | 0.74% | $1.84M |
| Centerbook partners lp | 1.47M | 0.20% | $3.30M |
| Redmile group | 1.05M | 0.14% | $2.35M |
| Alpine global management | 300.00K | 0.12% | $675.00K |
| Gsa capital partners llp | 605.66K | 0.10% | $1.36M |
| Powell investment advisors | 50.00K | 0.06% | $112.50K |
| Stoneridge investment partners | 53.21K | 0.05% | $120.00K |
| Fairfax financial ltd/ can | 170.94K | 0.03% | $382.90K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gsa capital partners llp | 605.66K | 0.10% | 593.95K |
| Blackrock | 10.33M | 0.00% | 371.57K |
| Renaissance | 1.35M | 0.01% | 342.30K |
| Morgan stanley | 1.61M | 0.00% | 318.97K |
| Rosalind advisors | 3.12M | 5.40% | 300.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | - | - | -4.83M |
| Ameriprise financial | 219.91K | 0.00% | -733.33K |
| Stonepine capital management | - | - | -598.09K |
| Invenomic capital management lp | - | - | -592.08K |
| Nea management company | - | - | -419.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Corebridge financial | 75.44K | 0.00% | 75.44K | $169.74K |
| Verition fund management | 74.23K | 0.00% | 74.23K | $167.03K |
| Mirae asset global etfs | 66.71K | 0.00% | 66.71K | $150.09K |
| Powell investment advisors | 50.00K | 0.06% | 50.00K | $112.50K |
| Franklin resources | 19.49K | - | 19.49K | $43.85K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -27.00 |
| Soa wealth advisors, llc. | -118.00 |
| Comerica bank | -417.00 |
| Federation des caisses desjardins du quebec | -570.00 |
| Adar1 capital management | -1.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 143 | 4.38% | 63,815,802 | 5.21% | 42 | 2.30% | 71 | 1.43% | 34 | -5.56% |
| Jun 30, 2024 | 137 | -6.16% | 60,658,095 | 0.07% | 43 | 2.32% | 70 | -17.65% | 36 | 9.09% |
| Mar 31, 2024 | 146 | 19.67% | 60,615,681 | 1.47% | 43 | 2.31% | 85 | 49.12% | 33 | 6.45% |
| Dec 31, 2023 | 122 | 7.02% | 59,735,564 | 8.86% | 43 | 2.74% | 57 | 9.62% | 31 | 19.23% |
| Sep 30, 2023 | 114 | 7.55% | 54,874,042 | -1.62% | 39 | 2.41% | 52 | 4.00% | 26 | -7.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.25M | 2.85% | - |
| iShares Russell 2000 ETF | 3.59M | 2.41% | -8.08K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.28M | 1.53% | -8.43K |
| Fidelity Small Cap Index | 1.43M | 0.96% | -30.83K |
| iShares Russell 2000 Growth ETF | 1.24M | 0.83% | - |
| CREF Stock R1 | 917.64K | 0.62% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 871.04K | 0.58% | -30.70K |
| Fidelity Extended Market Index | 867.55K | 0.58% | -58.48K |
| Vanguard Russell 2000 ETF | 640.69K | 0.43% | -3.98K |
| Kennedy Micro Cap | 526.07K | 0.35% | 526.07K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 12, 2024 | Schmid John P. | - | Buy | $10.15K |
| Aug 09, 2024 | Schmid John P. | - | Buy | $10.13K |
| May 10, 2024 | Schmid John P. | - | Buy | $10.31K |
| Mar 14, 2024 | Schmid John P. | - | Buy | $9.72K |
| Nov 27, 2023 | SHERMAN JEFFREY W | - | Buy | $10.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | 2 | - |
| 2024 Q2 | 1 | - |
| 2024 Q1 | 1 | - |
| 2023 Q4 | 6 | - |
| 2023 Q3 | 1 | - |
XERS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools